A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder

European Urology
Christopher Chapple, Claus G Roehrborn

Abstract

Lower urinary tract symptoms (LUTS) are highly prevalent among older men and have a negative impact on health-related quality of life. Frequent comorbidity with potential prostatic disease adds complexity to the management of male LUTS. In this review, we discuss the pathophysiological conditions that underlie male LUTS, and examine the relationship between symptoms and urodynamic findings. The contribution of bladder dysfunction to male LUTS, with a particular emphasis on overactive bladder (OAB) symptoms, is explored. We also consider pharmacotherapeutic options for male LUTS. Pharmacotherapies that target the prostate (alpha1-receptor antagonists and 5alpha-reductase inhibitors) often fail to alleviate OAB symptoms, and may not be the most appropriate therapy for men with storage LUTS. Multiple studies have suggested that antimuscarinic therapy alone or in combination with alpha1-receptor antagonists improve OAB symptoms in men with and without bladder outlet obstruction. Although these agents may represent appropriate first-line therapies for men with OAB symptoms, the therapeutic potential of antimuscarinics alone or in combination with alpha1-receptor antagonists in this population should be evaluated in large-scale, well...Continue Reading

Associated Clinical Trials

References

Nov 1, 1994·British Journal of Urology·J V JolleysP Abrams
Apr 9, 1994·BMJ : British Medical Journal·P Abrams
Jan 14, 1998·Urology·A F Brading
Mar 27, 1999·Urology·A ZiadaE D Crawford
Jan 13, 2001·BMJ : British Medical Journal·P Abrams
Jun 1, 2001·Neurourology and Urodynamics·T KnutsonC Dahlstrand
Jun 1, 2001·Neurourology and Urodynamics·L J RomanziJ G Blaivas
Feb 22, 2002·Neurourology and Urodynamics·Paul AbramsUNKNOWN Standardisation Sub-committee of the International Continence Society
Sep 28, 2002·Urology·Claus G RoehrbornUNKNOWN ARIA3001 ARIA3002 and ARIA3003 Study Investigators
Nov 12, 2002·Current Urology Reports·Khaled F Abdel-Aziz, Gary E Lemack
Dec 21, 2002·Urology·Jacek L Mostwin
Feb 1, 2003·Urology·Paul AbramsUNKNOWN Standardisation Sub-Committee of the International Continence Society
Mar 12, 2003·The Journal of Urology·Isao ArakiSadako Kuno
Jun 18, 2003·Urology·Teh-Wei HuTimothy L Hunt
Dec 25, 2003·Lancet Neurology·Karl-Erik Andersson
Feb 18, 2005·European Urology·Helmut Madersbacher
Nov 1, 2005·Expert Opinion on Investigational Drugs·Atul TiwariAnita Chugh

❮ Previous
Next ❯

Citations

Sep 29, 2011·JAMA : the Journal of the American Medical Association·Michael J BarryUNKNOWN Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Study Group
Jul 6, 2011·Der Urologe. Ausg. A·P RotheS Mühlich
Jul 12, 2012·Der Urologe. Ausg. A·F StrittmatterC Gratzke
Mar 19, 2009·World Journal of Urology·Ricardo NatalinCarlos A L D'Ancona
Aug 26, 2009·World Journal of Urology·Osamu YamaguchiMasanori Nomiya
Sep 17, 2010·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Jennifer L St SauverSteven J Jacobsen
Feb 2, 2008·International Urology and Nephrology·K StamatiouE Skoumbourdis
Aug 28, 2009·Current Urology Reports·Richard T Kershen
Dec 3, 2010·Current Urology Reports·Doreen E Chung, Jaspreet S Sandhu
Aug 6, 2013·Current Urology Reports·Oscar SuarezRoger Dmochowski
Dec 12, 2012·Asian Journal of Andrology·Hui DingZhi-Ping Wang
Jul 7, 2007·Nature Clinical Practice. Urology·Karl-Erik Andersson, Christian Gratzke
Aug 19, 2009·Prostate Cancer and Prostatic Diseases·S Mouli, K T McVary
Jul 13, 2007·International Journal of Impotence Research·P SandnerE Bischoff
Dec 16, 2006·International Journal of Clinical Practice. Supplement·K-E Andersson
Nov 18, 2006·International Journal of Clinical Practice·M J NaslundM M Miner
Jan 8, 2011·International Journal of Clinical Practice·S A KaplanZ Guan
Jan 26, 2008·BMJ : British Medical Journal·Timothy J Wilt, James N'Dow
Oct 1, 2009·Therapeutic Advances in Urology·Roger R Dmochowski, Alex Gomelsky
Dec 1, 2010·Drug Design, Development and Therapy·Maxime Rossi, Thierry Roumeguère
Mar 21, 2012·Drugs & Aging·Seth A Cohen, J Kellogg Parsons
Nov 11, 2008·Biomedical Research·Haruko YanaseMasahito Kawatani
Dec 28, 2007·European Urology·Lambertus P W WitteMartin C Michel
Dec 17, 2009·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Steven A KaplanSergio Forero-Schwanhaeuser
Jul 11, 2008·Expert Opinion on Drug Safety·Anastasios AthanasopoulosPetros Perimenis
Dec 15, 2015·International Journal of Surgery·Haitham AbdelmotelebMarcus J Drake
Jan 13, 2016·Nature Reviews. Urology·Linda VignozziMario Maggi
May 16, 2009·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Shiu-Dong Chung, Hong-Jeng Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.